Klump Michael A 4
4 · CytoDyn Inc. · Filed Jan 8, 2020
Insider Transaction Report
Form 4
CytoDyn Inc.CYDY
Klump Michael A
Director
Transactions
- Award
Convertible Promissory Note
2019-10-08+537,397(indirect: See Footnote)Exercise: $0.50From: 2019-10-08Exp: 2020-04-01→ Common Stock (1,075,758 underlying) - Award
Warrant (Right to Buy)
2019-10-08+500,000→ 500,000 total(indirect: See Footnote)Exercise: $0.30From: 2019-10-07Exp: 2024-10-08→ Common Stock (500,000 underlying) - Disposition to Issuer
Convertible Promissory Note
2019-10-08−500,000(indirect: See Footnote)Exercise: $0.50From: 2019-01-08Exp: 2019-10-08→ Common Stock (1,000,000 underlying)
Footnotes (2)
- [F1]The reported securities of CytoDyn Inc. (the "Company") are held by Argonne Trading, LLC, a Georgia limited liability company ("Argonne Trading"). Argonne Capital Group, LLC, a Georgia limited liability company ("Argonne Capital"), is the sole member of Argonne Trading. Michael A. Klump is Manager, President and Chief Executive Officer of Argonne Capital. Mr. Klump disclaims beneficial ownership of the securities held by Argonne Trading, except to the extent of his pecuniary interest therein
- [F2]The Company recently completed a convertible promissory note exchange offer in which Argonne Trading participated, among other non-affiliated investors. Pursuant to the exchange offer, as an inducement to extend the maturity date of a certain convertible promissory note (the "Original Note") beneficially owned by Mr. Klump, the Company (i) issued a new convertible promissory note in the principal amount equal to the principal amount of the Original Note plus the accrued but unpaid interest thereon and (ii) issued a warrant to purchase shares of common stock covering fifty percent of the shares of common stock into which the principal amount of the Original Note was convertible.